ATOSSA THERAPEUTICS, INC. (ATOS) Operating income 2016–2025
ATOSSA THERAPEUTICS, INC. (ATOS) annual operating income history from SEC filings — each fiscal year as reported.
-$37.1MFY2025 · since FY2016: -$8.0M → -$37.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$37.1M | -34.5% |
| FY2024 | -$27.6M | +12.0% |
| FY2023 | -$31.4M | -13.3% |
| FY2022 | -$27.7M | -34.9% |
| FY2021 | -$20.5M | -40.5% |
| FY2020 | -$14.6M | +15.4% |
| FY2019 | -$17.3M | -51.0% |
| FY2018 | -$11.4M | -49.5% |
| FY2017 | -$7.6M | +4.0% |
| FY2016 | -$8.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ATOS financial trends
ATOS RevenueATOS Net incomeATOS Net marginATOS Gross profitATOS Gross marginATOS Operating marginATOS Operating cash flowATOS Free cash flowATOS Capital expendituresATOS Return on equityATOS Stock buybacksATOS Dividends paidATOS Total assetsATOS Total liabilitiesATOS Shareholders’ equityATOS overview →